BMS-986369 (Golcadomide)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986369 (Golcadomide), covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3) [Phase 1, Phase 2]